BSH 2017 | Potential clinical impact of genomic analysis in CLL
Elias Campo
• 27 Mar 2017
Elias Campo, MD, PhD from the University of Barcelona, Hospital Clinic, Barcelona, Spain discusses the potential clinical impact of genomic analysis in chronic lymphocytic leukemia (CLL). Prof. Campo explains that the new technologies that have been developed to analyze the DNA sequence, have provided new perspectives of the genetic alterations that may be underlying the pathogenesis of CLL. Prof. Campo talks about whole genome sequencing (WGS) and whole exome sequencing (WES) analyses, which have given insight into the genetic heterogeneity of CLL, and he also discusses the next steps for this research.
Recorded at the 2017 British Society for Haematology (BSH) Annual Scientific Meeting in Brighton, UK.
